48. Insulins are considered to be high-alert medications because of the potential for serious adverse effects, such as:
Answer: A
Insulins can cause hypoglycemia, making them high-alert medications.
Insulins are labeled as high-alert medications primarily due to their potential to induce hypoglycemia, a serious adverse effect that can lead to significant health complications if not promptly addressed.
A) hypoglycemia.
This option is correct as hypoglycemia is a well-documented and serious adverse effect of insulin administration. It occurs when blood glucose levels drop too low, which can lead to confusion, seizures, loss of consciousness, and even death if not treated quickly. The risk of hypoglycemia is a critical reason why insulin use requires careful monitoring and management.
B) hypothyroidism.
Hypothyroidism is incorrect in this context as it is not directly associated with insulin use. While thyroid function can impact glucose metabolism, hypothyroidism itself does not result from the administration of insulin. Therefore, it does not represent a high-alert concern related to insulin therapy.
C) hyperlipidemia.
Hyperlipidemia, characterized by elevated levels of lipids in the blood, is not a direct or immediate effect of insulin use. While insulin can influence lipid metabolism, it does not typically result in hyperlipidemia as a direct adverse effect. Thus, this option does not align with the serious risks associated with insulin medications.
D) hypernatremia.
Hypernatremia refers to high sodium levels in the blood, which is not a typical concern associated with insulin therapy. Insulin does not generally cause hypernatremia; thus, this option does not pertain to the high-alert classification of insulin medications.
Conclusion
Hypoglycemia is the primary serious adverse effect associated with insulin, justifying its classification as a high-alert medication. The other options, while they may be relevant in broader contexts of patient health, do not reflect the acute risks linked to insulin therapy. Therefore, hypoglycemia is the definitive concern that healthcare providers must monitor closely when administering insulin.